ISRCTN47375023已完成不适用
Safety and efficacy of single-dose and triple-dose albendazole and mebendazole against soil-transmitted helminth infections in humans: open-label randomised-controlled trial in China
Swiss Tropical Institute (STI) (Switzerland)0 个研究点目标入组 370 人开始时间: 2008年11月28日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 370
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Age: greater than or equal to 5 years old
- •2. Sex: males and females
- •3. Residency: resident of Nongyang village in Menghai county, Yunnan province, People?s Republic of China
- •4. Registration, participation: signing of written informed consent sheet (5 - 17 year olds: additional written approval by parents or legal guardians), willingness to comply with study procedures (stool submission, drug treatment, alcohol abstinence at day of treatment)
- •5. Absence of systemic or chronic diagnosed or perceivable illness as assessed by medical personnel upon enrolment and again at each day of treatment
- •6. Females: not pregnant (as verbally assessed by female medical personnel upon enrolment and again at each day of treatment)
排除标准
- •1. Age: less than 5 years
- •2. Residency: not a permanent resident of Nongyang village in Menghai county, Yunnan province, People?s Republic of China
- •3. Registration, participation: no written informed consent sheet signed or parental approval not obtained, unwillingness to comply with all study procedures
- •4. Presence or suspicion of any abnormal medical condition which is known or suspected to interfere with anthelminthic treatment
- •5. Known hypersensitivity to any anthelminthic drugs
- •6. Recent history of anthelminthic treatment
- •7. Current or past (within 1 month) participation in any other medical trial
- •8. For females: suspected or verified pregnancy
研究者
相似试验
进行中（未招募）
不适用
Clinical trials assessing efficacy, safety and tolerability of different doses of oral cebranopadol in patients with moderate to severe chronic pain due to diabetic peripheral neuropathyEUCTR2013-000473-68-NLGrünenthal GmbH350
进行中（未招募）
不适用
Clinical trials assessing efficacy, safety and tolerability of different doses of oral cebranopadol in patients with moderate to severe chronic pain due to diabetic peripheral neuropathyEUCTR2013-000473-68-DEGrünenthal GmbH699
进行中（未招募）
不适用
Clinical trials assessing efficacy, safety and tolerability of different doses of oral cebranopadol in patients with moderate to severe chronic pain due to diabetic peripheral neuropathyModerate to severe chronic pain due to diabetic peripheral neuropathy (DPN) requiring analgesia in subjects with well-controlled and stable type 1 or type 2 diabetes mellitus.MedDRA version: 16.0Level: PTClassification code 10012680Term: Diabetic neuropathySystem Organ Class: 10029205 - Nervous system disordersEUCTR2013-000473-68-ESGrünenthal GmbH540
进行中（未招募）
不适用
Clinical trials assessing efficacy, safety and tolerability of different doses of oral cebranopadol in patients with moderate to severe chronic pain due to diabetic peripheral neuropathyModerate to severe chronic pain due to diabetic peripheral neuropathy (DPN) requiring analgesia in subjects with well-controlled and stable type 1 or type 2 diabetes mellitus.MedDRA version: 16.0Level: PTClassification code 10012680Term: Diabetic neuropathySystem Organ Class: 10029205 - Nervous system disordersEUCTR2013-000473-68-BEGrünenthal GmbH540
进行中（未招募）
不适用
Clinical trials assessing efficacy, safety and tolerability of different doses of oral cebranopadol in patients with moderate to severe chronic pain due to diabetic peripheral neuropathyModerate to severe chronic pain due to diabetic peripheral neuropathy (DPN) requiring analgesia in subjects with well-controlled and stable type 1 or type 2 diabetes mellitus.MedDRA version: 17.1Level: PTClassification code 10012680Term: Diabetic neuropathySystem Organ Class: 10029205 - Nervous system disordersEUCTR2013-000473-68-ATGrünenthal GmbH699